An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A new warning is getting attention: some doctors say people who take weight-loss drugs like Ozempic should stop them before surgery. The concern is that these medicines can slow how fast the stomach empties, and after an operation that involves anesthesia, a full or slow-emptying stomach can increase the risk of food or liquid getting into the lungs. That can cause a dangerous complication called aspiration pneumonia. Drugs like Ozempic contain semaglutide, which is a man-made version of a hormone your gut releases after you eat. That hormone tells your brain you’re full and also slows digestion so food stays in your stomach longer. In normal terms, the medicine tricks your body into feeling satisfied sooner and keeps food moving through the gut more slowly, which helps some people lose weight. It’s sold under several brand names for diabetes and weight loss. What the reports are flagging is mostly a clinical concern based on how these drugs work and on some case reports and surgical guidelines, not a huge randomized study proving harm in every situation. Anesthesiologists already worry about anything that delays stomach emptying because anesthesia removes the reflex that keeps stomach contents from rising into the throat. A few hospitals and doctors are advising patients to pause GLP-1 drugs (the drug class that includes semaglutide) for a period before elective surgery. The exact recommendations vary, and there isn’t a single large study that quantifies the added risk for every patient. This matters if you’re taking one of these medications and planning to have surgery. For people having planned procedures, the advice could mean talking to your surgeon or anesthesiologist about pausing the drug for a recommended number of days beforehand. That could reduce a potential risk during the operation. If you’re on the medication for diabetes management or weight control, your medical team will balance that benefit against the short-term risk of stopping it. There are important caveats. Guidance varies by hospital and by individual health needs. Stopping diabetes or weight-loss medication suddenly can affect blood sugar and other health parameters, so don’t stop on your own—talk to the clinician managing your care. The evidence prompting these cautions is not from huge controlled trials, so recommendations may change as more data appear. Also, in emergency surgery you won’t have the luxury of pausing the drug beforehand, and doctors will take other steps to reduce risk. Bottom line: Because these drugs slow stomach emptying, some doctors suggest pausing them before planned surgery to lower a potential aspiration risk, but decisions should be individualized and made with your medical team.
Source: nypost.com